(CTAS) Cintas - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1729081059
Uniforms, Mats, First Aid, Fire Protection
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.88% |
| Yield on Cost 5y | 2.05% |
| Yield CAGR 5y | 11.00% |
| Payout Consistency | 90.7% |
| Payout Ratio | 29.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.0% |
| Value at Risk 5%th | 30.4% |
| Relative Tail Risk | -7.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -7.35 |
| CAGR/Max DD | 1.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.273 |
| Beta | 0.598 |
| Beta Downside | 0.528 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.88% |
| Mean DD | 4.81% |
| Median DD | 2.61% |
Description: CTAS Cintas December 03, 2025
Cintas Corporation (NASDAQ:CTAS) provides corporate-identity uniforms and a suite of related business services across the United States, Canada, and Latin America. Its operations are organized into three segments: Uniform Rental & Facility Services, First Aid & Safety Services, and All Other, covering rental and servicing of work apparel (including flame-resistant gear), cleaning supplies, restroom hygiene solutions, and fire-protection products. The company reaches customers through a network of distribution centers, local delivery routes, and field representatives serving both small manufacturers and large enterprises.
Key recent metrics show Cintas generated ≈ $7.6 billion in revenue for FY 2023, with an adjusted earnings-per-share of $6.27 and an operating margin near 13 %. Same-store sales growth has been modest (≈ 3 % YoY), reflecting a competitive uniform-rental market, while the First Aid & Safety segment has outperformed, expanding at ~5 % driven by heightened workplace safety regulations and ongoing inflation-linked demand for personal protective equipment. A primary sector driver is corporate spending on compliance-related services, which tends to be counter-cyclical to broader economic downturns.
For a deeper quantitative view, you may want to explore Cintas’ metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (1.90b TTM) > 0 and > 6% of Revenue (6% = 647.7m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA -2.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 13.56% (prev -0.27%; Δ 13.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 2.20b > Net Income 1.90b (YES >=105%, WARN >=100%) |
| Net Debt (3.04b) to EBITDA (2.86b) ratio: 1.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (406.4m) change vs 12m ago -1.03% (target <= -2.0% for YES) |
| Gross Margin 50.25% (prev 48.79%; Δ 1.46pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 110.7% (prev 106.1%; Δ 4.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 18.14 (EBITDA TTM 2.86b / Interest Expense TTM 101.1m) >= 6 (WARN >= 3) |
Altman Z'' 9.02
| (A) 0.14 = (Total Current Assets 3.54b - Total Current Liabilities 2.08b) / Total Assets 10.13b |
| (B) 1.23 = Retained Earnings (Balance) 12.42b / Total Assets 10.13b |
| warn (B) unusual magnitude: 1.23 — check mapping/units |
| (C) 0.19 = EBIT TTM 1.83b / Avg Total Assets 9.75b |
| (D) 2.68 = Book Value of Equity 15.23b / Total Liabilities 5.68b |
| Total Rating: 9.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.30
| 1. Piotroski 7.50pt |
| 2. FCF Yield 2.21% |
| 3. FCF Margin 16.50% |
| 4. Debt/Equity 0.73 |
| 5. Debt/Ebitda 1.06 |
| 6. ROIC - WACC (= 12.37)% |
| 7. RoE 41.07% |
| 8. Rev. Trend 99.18% |
| 9. EPS Trend -75.89% |
What is the price of CTAS shares?
As of December 31, 2025, the stock is trading at USD 190.35 with a total of 791,993 shares traded.
Over the past week, the price has changed by -0.16%, over one month by +2.65%, over three months by -6.43% and over the past year by +4.48%.
Over the past week, the price has changed by -0.16%, over one month by +2.65%, over three months by -6.43% and over the past year by +4.48%.
Is CTAS a buy, sell or hold?
Cintas has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold CTAS.
- Strong Buy: 5
- Buy: 3
- Hold: 8
- Sell: 1
- Strong Sell: 3
What are the forecasts/targets for the CTAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 213.9 | 12.4% |
| Analysts Target Price | 213.9 | 12.4% |
| ValueRay Target Price | 222.1 | 16.7% |
CTAS Fundamental Data Overview December 24, 2025
Market Cap USD = 77.36b (77.36b USD * 1.0 USD.USD)
P/E Trailing = 40.6759
P/E Forward = 38.7597
P/S = 7.1665
P/B = 16.9186
P/EG = 3.542
Beta = 0.963
Revenue TTM = 10.79b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 2.86b USD
Long Term Debt = 2.42b USD (from longTermDebt, last fiscal year)
Short Term Debt = 603.5m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = 80.40b USD (77.36b + Debt 3.24b - CCE 200.8m)
Interest Coverage Ratio = 18.14 (Ebit TTM 1.83b / Interest Expense TTM 101.1m)
FCF Yield = 2.21% (FCF TTM 1.78b / Enterprise Value 80.40b)
FCF Margin = 16.50% (FCF TTM 1.78b / Revenue TTM 10.79b)
Net Margin = 17.58% (Net Income TTM 1.90b / Revenue TTM 10.79b)
Gross Margin = 50.25% ((Revenue TTM 10.79b - Cost of Revenue TTM 5.37b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 50.28%)
Tobins Q-Ratio = 7.93 (Enterprise Value 80.40b / Total Assets 10.13b)
Interest Expense / Debt = 0.87% (Interest Expense 28.1m / Debt 3.24b)
Taxrate = 21.19% (133.2m / 628.5m)
NOPAT = 1.44b (EBIT 1.83b * (1 - 21.19%))
Current Ratio = 1.71 (Total Current Assets 3.54b / Total Current Liabilities 2.08b)
Debt / Equity = 0.73 (Debt 3.24b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = 1.06 (Net Debt 3.04b / EBITDA 2.86b)
Debt / FCF = 1.71 (Net Debt 3.04b / FCF TTM 1.78b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.73% (Net Income 1.90b / Total Assets 10.13b)
RoE = 41.07% (Net Income TTM 1.90b / Total Stockholder Equity 4.62b)
RoCE = 26.01% (EBIT 1.83b / Capital Employed (Equity 4.62b + L.T.Debt 2.42b))
RoIC = 20.29% (NOPAT 1.44b / Invested Capital 7.12b)
WACC = 7.92% (E(77.36b)/V(80.60b) * Re(8.22%) + D(3.24b)/V(80.60b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.81%
[DCF Debug] Terminal Value 78.34% ; FCFE base≈1.81b ; Y1≈1.90b ; Y5≈2.21b
Fair Price DCF = 92.95 (DCF Value 37.45b / Shares Outstanding 402.9m; 5y FCF grow 5.10% → 3.0% )
EPS Correlation: -75.89 | EPS CAGR: -19.19% | SUE: 0.12 | # QB: 0
Revenue Correlation: 99.18 | Revenue CAGR: 9.97% | SUE: 2.49 | # QB: 2
EPS next Quarter (2026-02-28): EPS=1.23 | Chg30d=+0.011 | Revisions Net=+3 | Analysts=11
EPS current Year (2026-05-31): EPS=4.88 | Chg30d=-0.006 | Revisions Net=+8 | Growth EPS=+10.8% | Growth Revenue=+8.3%
EPS next Year (2027-05-31): EPS=5.40 | Chg30d=+0.059 | Revisions Net=+7 | Growth EPS=+10.7% | Growth Revenue=+7.1%
P/E Trailing = 40.6759
P/E Forward = 38.7597
P/S = 7.1665
P/B = 16.9186
P/EG = 3.542
Beta = 0.963
Revenue TTM = 10.79b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 2.86b USD
Long Term Debt = 2.42b USD (from longTermDebt, last fiscal year)
Short Term Debt = 603.5m USD (from shortTermDebt, last quarter)
Debt = 3.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.04b USD (from netDebt column, last quarter)
Enterprise Value = 80.40b USD (77.36b + Debt 3.24b - CCE 200.8m)
Interest Coverage Ratio = 18.14 (Ebit TTM 1.83b / Interest Expense TTM 101.1m)
FCF Yield = 2.21% (FCF TTM 1.78b / Enterprise Value 80.40b)
FCF Margin = 16.50% (FCF TTM 1.78b / Revenue TTM 10.79b)
Net Margin = 17.58% (Net Income TTM 1.90b / Revenue TTM 10.79b)
Gross Margin = 50.25% ((Revenue TTM 10.79b - Cost of Revenue TTM 5.37b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 50.28%)
Tobins Q-Ratio = 7.93 (Enterprise Value 80.40b / Total Assets 10.13b)
Interest Expense / Debt = 0.87% (Interest Expense 28.1m / Debt 3.24b)
Taxrate = 21.19% (133.2m / 628.5m)
NOPAT = 1.44b (EBIT 1.83b * (1 - 21.19%))
Current Ratio = 1.71 (Total Current Assets 3.54b / Total Current Liabilities 2.08b)
Debt / Equity = 0.73 (Debt 3.24b / totalStockholderEquity, last quarter 4.46b)
Debt / EBITDA = 1.06 (Net Debt 3.04b / EBITDA 2.86b)
Debt / FCF = 1.71 (Net Debt 3.04b / FCF TTM 1.78b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.73% (Net Income 1.90b / Total Assets 10.13b)
RoE = 41.07% (Net Income TTM 1.90b / Total Stockholder Equity 4.62b)
RoCE = 26.01% (EBIT 1.83b / Capital Employed (Equity 4.62b + L.T.Debt 2.42b))
RoIC = 20.29% (NOPAT 1.44b / Invested Capital 7.12b)
WACC = 7.92% (E(77.36b)/V(80.60b) * Re(8.22%) + D(3.24b)/V(80.60b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.81%
[DCF Debug] Terminal Value 78.34% ; FCFE base≈1.81b ; Y1≈1.90b ; Y5≈2.21b
Fair Price DCF = 92.95 (DCF Value 37.45b / Shares Outstanding 402.9m; 5y FCF grow 5.10% → 3.0% )
EPS Correlation: -75.89 | EPS CAGR: -19.19% | SUE: 0.12 | # QB: 0
Revenue Correlation: 99.18 | Revenue CAGR: 9.97% | SUE: 2.49 | # QB: 2
EPS next Quarter (2026-02-28): EPS=1.23 | Chg30d=+0.011 | Revisions Net=+3 | Analysts=11
EPS current Year (2026-05-31): EPS=4.88 | Chg30d=-0.006 | Revisions Net=+8 | Growth EPS=+10.8% | Growth Revenue=+8.3%
EPS next Year (2027-05-31): EPS=5.40 | Chg30d=+0.059 | Revisions Net=+7 | Growth EPS=+10.7% | Growth Revenue=+7.1%
Additional Sources for CTAS Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle